Oral Semaglutide in Patients With Alzheimer's Disease

Clinical trial NCT07200622 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07200622
Sponsor: Imperial College London
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-09-25
Primary completion: 2027-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.